Sol Langermann

Insider Reports History

Location
Beltsville, MD
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Sol Langermann
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sol Langermann:

Company Role Class Num Shares Value Price $ Report Date Ownership
NextCure, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 117,375 31 Jan 2025 Direct
NextCure, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 93,900 29 Mar 2024 Direct

Insider Reports Filed by Sol Langermann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NXTC NextCure, Inc. 31 Jan 2025 1 $0 4 Chief Scientific Officer 03 Feb 2025, 18:22
NXTC NextCure, Inc. 29 Mar 2024 1 $0 4 Chief Scientific Officer 02 Apr 2024, 16:41
NXTC NextCure, Inc. 31 Jan 2024 1 $0 4 Chief Scientific Officer 01 Feb 2024, 16:44
NXTC NextCure, Inc. 28 Feb 2023 1 $0 4 Chief Scientific Officer 01 Mar 2023, 17:01
NXTC NextCure, Inc. 31 Jan 2022 1 $0 4 Chief Scientific Officer 02 Feb 2022, 15:20